{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:45:53Z","timestamp":1772826353980,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.vaccine.2012.11.072","type":"journal-article","created":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T14:31:17Z","timestamp":1355495477000},"page":"806-812","source":"Crossref","is-referenced-by-count":24,"title":["Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice"],"prefix":"10.1016","volume":"31","author":[{"given":"Paula","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"Zylberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselle","family":"Ghersi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Boado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Goldbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Mattion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2012.11.072_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2007.10.017","article-title":"Emerging influenza","volume":"41","author":"de Wit","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0010","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature08182","article-title":"Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic","volume":"459","author":"Smith","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.072_bib0015","first-page":"202","article-title":"Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus: II. Protection from influenza infection and mechanism of protection","volume":"71","author":"Tite","year":"1990","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0020","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virol.2005.04.004","article-title":"Universal influenza A vaccine: optimization of M2-based constructs","volume":"337","author":"De Filette","year":"2005","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.072_bib0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2012.11.072_bib0040","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0045","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0042-6822(91)90075-M","article-title":"Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel","volume":"180","author":"Sugrue","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0055","doi-asserted-by":"crossref","first-page":"8391","DOI":"10.1128\/JVI.70.12.8391-8401.1996","article-title":"Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins","volume":"70","author":"Bui","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0060","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1083\/jcb.133.4.733","article-title":"The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus","volume":"133","author":"Sakaguchi","year":"1996","journal-title":"J Cell Biol"},{"issue":"10","key":"10.1016\/j.vaccine.2012.11.072_bib0065","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0070","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0264-410X(03)00040-9","article-title":"Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2","volume":"21","author":"Mozdzanowska","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.072_bib0075","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/JVI.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice","volume":"64","author":"Treanor","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2004.05.028","article-title":"High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity","volume":"23","author":"Liu","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.072_bib0085","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.vaccine.2005.08.061","article-title":"The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection","volume":"24","author":"De Filette","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jps.20493","article-title":"Pharmaceutical and immunological evaluation of human papillomavirus virus like particle as an antigen carrier","volume":"95","author":"Ionescu","year":"2006","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.072_bib0095","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0100","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.vaccine.2008.12.034","article-title":"Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys","volume":"27","author":"Fu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0110","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1743-422X-4-118","article-title":"Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse","volume":"4","author":"Mozdzanowska","year":"2007","journal-title":"Virol J"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.072_bib0120","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.70.5.2507-2511.2002","article-title":"A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB\/c mice","volume":"70","author":"Velikovsky","year":"2002","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2012.11.072_bib0125","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1\u2013Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.072_bib0130","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/prot.20248","article-title":"Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides","volume":"57","author":"Laplagne","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0135","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1074\/jbc.M312035200","article-title":"High order quaternary arrangement confers increased structural stability to Brucella sp. lumazine synthase","volume":"279","author":"Zylberman","year":"2004","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.vaccine.2012.11.072_bib0140","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1099\/00222615-48-9-833","article-title":"The 18-kDa cytoplasmic protein of Brucella species \u2013 an antigen useful for diagnosis \u2013 is a lumazine synthase","volume":"48","author":"Goldbaum","year":"1999","journal-title":"J Med Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2012.11.072_bib0145","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/JCM.31.8.2141-2145.1993","article-title":"Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis","volume":"31","author":"Goldbaum","year":"1993","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.072_bib0150","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1021\/bm201875p","article-title":"Polymeric display of proteins through high affinity leucine zipper peptide adaptors","volume":"13","author":"Craig","year":"2012","journal-title":"Biomacromolecules"},{"issue":"32","key":"10.1016\/j.vaccine.2012.11.072_bib0155","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e\u2013flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0160","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of Matrix Protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.072_bib0165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.addr.2004.09.006","article-title":"ISCOMATRIX\u00ae adjuvant for antigen delivery","volume":"57","author":"Pearse","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.072_bib0170","article-title":"ISCOMATRIX\u00ae vaccines: safety in human clinical studies","volume":"30","author":"McKenzie","year":"2010","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0175","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1016\/j.vaccine.2011.07.136","article-title":"\u03b1-Galactosylceramide potently augments M2e-induced protective immunity against highly pathogenic H5N1 avian influenza virus infection in mice","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.072_bib0180","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.micinf.2005.12.006","article-title":"Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity","volume":"8","author":"Rosas","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2012.11.072_bib0185","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.072_bib0190","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.4049\/jimmunol.135.3.2183","article-title":"Influence of antibody isotype on passive serotherapy of lymphoma","volume":"135","author":"Denkers","year":"1985","journal-title":"J Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2012.11.072_bib0195","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/0961203309345724","article-title":"Adjuvants and autoimmunity","volume":"18","author":"Israeli","year":"2009","journal-title":"Lupus"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12017227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12017227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T10:03:28Z","timestamp":1714730608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12017227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0264410X12017227"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}